| Daniel Alan Hale, MD | |
|
9705 Lenexa Dr, Lenexa, KS 66215-1345 | |
| (816) 241-3338 | |
| (816) 936-8118 |
| Full Name | Daniel Alan Hale |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 10 Years |
| Location | 9705 Lenexa Dr, Lenexa, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477972610 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZH0000X | Pathology - Hematology | 04-42115 (Kansas) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 04-42115 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor University Medical Center | Dallas, TX | Hospital |
| Baylor Scott & White Medical Center Grapevine | Grapevine, TX | Hospital |
| Baylor Scott & White Medical Center Plano | Plano, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pathologists Bio-medical Laboratories Pllc | 7911961677 | 46 |
News Archive
ZO Skin Health, Inc. is excited to reveal two new products developed by Zein Obagi, MD to further enhance the ZO Skin Health Circle continuum of care – ZO Medical C-Bright 10% Vitamin C Serum and ZO Medical Brightalive Non-Retinol Skin Brightener.
The nanopharmaceutical drug CRLX101 is showing promise as a potential new treatment for cancers that develop resistance to antiangiogenic drugs and radiation therapy, according to clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23.
Exco InTouch, a leading provider of digital health technology, announces the launch of the TARGET My Hives app for Android– the digital healthcare platform is now available in both Android and iOS systems.
Zogenix, Inc., a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen. ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy for the control of pain.
Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, recently announced that their technology is now being incorporated into groundbreaking research in Spain in partnership with the University of Navarra, and involving over 800 participants.
› Verified 5 days ago
| Entity Name | Pathologists Bio-medical Laboratories Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265477707 PECOS PAC ID: 7911961677 Enrollment ID: O20041112001162 |
News Archive
ZO Skin Health, Inc. is excited to reveal two new products developed by Zein Obagi, MD to further enhance the ZO Skin Health Circle continuum of care – ZO Medical C-Bright 10% Vitamin C Serum and ZO Medical Brightalive Non-Retinol Skin Brightener.
The nanopharmaceutical drug CRLX101 is showing promise as a potential new treatment for cancers that develop resistance to antiangiogenic drugs and radiation therapy, according to clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23.
Exco InTouch, a leading provider of digital health technology, announces the launch of the TARGET My Hives app for Android– the digital healthcare platform is now available in both Android and iOS systems.
Zogenix, Inc., a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen. ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy for the control of pain.
Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, recently announced that their technology is now being incorporated into groundbreaking research in Spain in partnership with the University of Navarra, and involving over 800 participants.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Alan Hale, MD 9705 Lenexa Dr, Lenexa, KS 66215-1345 Ph: (816) 241-3338 | Daniel Alan Hale, MD 9705 Lenexa Dr, Lenexa, KS 66215-1345 Ph: (816) 241-3338 |
News Archive
ZO Skin Health, Inc. is excited to reveal two new products developed by Zein Obagi, MD to further enhance the ZO Skin Health Circle continuum of care – ZO Medical C-Bright 10% Vitamin C Serum and ZO Medical Brightalive Non-Retinol Skin Brightener.
The nanopharmaceutical drug CRLX101 is showing promise as a potential new treatment for cancers that develop resistance to antiangiogenic drugs and radiation therapy, according to clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23.
Exco InTouch, a leading provider of digital health technology, announces the launch of the TARGET My Hives app for Android– the digital healthcare platform is now available in both Android and iOS systems.
Zogenix, Inc., a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen. ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy for the control of pain.
Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, recently announced that their technology is now being incorporated into groundbreaking research in Spain in partnership with the University of Navarra, and involving over 800 participants.
› Verified 5 days ago
Dr. Robert S Strobach, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 14425 College Blvd Ste 130, Lenexa, KS 66215 Phone: 913-361-8528 Fax: 913-495-9743 | |
Dr. Monisha Dandekar, Pathology Medicare: Accepting Medicare Assignments Practice Location: 10101 Renner Blvd, Sutie A, Lenexa, KS 66219 Phone: 866-455-5305 Fax: 866-691-5318 | |
Dr. Ossama W Tawfik, M.D.,PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 14425 College Blvd Ste 130, Lenexa, KS 66215 Phone: 913-396-8509 | |
Dr. Charles T. Beavers, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 11070 Strang Line Rd, Lenexa, KS 66215 Phone: 816-241-3338 | |
Erin N Faber, DO Pathology Medicare: Accepting Medicare Assignments Practice Location: 9705 Lenexa Dr, Lenexa, KS 66215 Phone: 816-241-3338 Fax: 816-936-8118 | |
Kenneth Spengel, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 14425 College Blvd Ste 130, Lenexa, KS 66215 Phone: 913-396-8509 Fax: 913-495-9743 |